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Criteria for the design of peptide vaccines to prevent AIDS are presented. The best vaccine candidates con- 
tain both B and T lymphocyte-defied epitopes in regions conserved in sequence between viral isolates. We 
propose that attention should focus on proteins pecified by the gag and, possibly, pol genes in addition 
to the env gene envelope glycoproteins being actively studied. The predictions of B- and T-epitopes are re- 
fined by consideration of secondary structure prediction and inter-isolate sequence variability to suggest 
peptides from env, gag and pol that would be the best vaccine candidates. 
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1. INTRODUCTION 
The dramatic spread of the human immunodefi- 
ciency virus (HIV-l) highlights the need for 
prevention of AIDS (acquired immune deficiency 
syndrome) by a vaccine (e.g. (l-61). Towards this 
goal, the nucleotide sequences of several virus 
isolates have been determined [7-lo] and they con- 
tain the three main retroviral genes (5 ’ to 3 ‘) - 
gag, pol and env. gag encodes three proteins: ~17, 
p24 (the major capsid protein) and ~15 (a nucleic 
acid-binding protein); pol specifies a protease, a 
reverse transcriptase and an endonuclease and env 
determines the envelope glycoprotein and a 
transmembrane protein. 
The search for vaccines has focussed on B 
lymphocyte-defined epitopes (B-epitopes) of env 
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proteins [l-5] encouraged by the use of retroviral 
envelope proteins to confer protection against viral 
challenge in animals [ 111. Experimental identifica- 
tion of env B-epitopes by synthetic peptides [1,2] 
and by recombinant DNA technology [3] is often 
guided by predictions (e.g. [4]) that scan for local 
maxima in hydrophilicity [ 121. As B-epitopes are 
often loops between the regular secondary struc- 
tures [13], a further guide to their location would 
be to predict from the sequence which parts of the 
chain are not cu-helices or P-sheets [ 14-171. 
However, the importance of antibodies alone as 
the protective arm of the immune response is in 
doubt as, for instance, patients can die of AIDS 
with high levels of anti-env antibody in their blood 
[ 181. In addition, only low levels of neutralising 
antibodies are present in HIV-l infection and per- 
sist in AIDS [19,20]. Thus, cell-mediated immuni- 
ty, particularly cytotoxic T-cells, may play an 
important role in resistance to HIV-l as this type 
of cell induces protection in chronic viral infection 
[21]. The locations [22] of T lymphocyte-defined 
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epitopes (T-epitopes), which generally are on dif- 
ferent parts of the protein from B-epitopes [ 12,131, 
can to some extent be predicted [22]. 
2.2. Secondary structure prediction 
Any successful vaccine must be effective against 
a range of isolates. Thus, we consider that the best 
candidates for peptide vaccines should be one or 
several sections of the chain with both B- and T- 
epitopes that are conserved in sequence. 
Recently, clinical progression to AIDS has been 
associated with a reduction in antibodies to the 
main capsid protein, gag p24 [23]. Thus, stimula- 
tion of these antibodies by a gag vaccine might pre- 
vent the onset of AIDS. In general, we propose 
that the search for a peptide vaccine should con- 
sider not only the env proteins but also those from 
gag and perhaps even pol. One strategy might be to 
include components from several proteins in the 
vaccine. 
The algorithms of Zvelebil et al. [14], Chou and 
Fasman [15], Lim [16] and Rose [17] were used to 
predict cu-helices, &sheets and bends in the pro- 
teins. There is considerable variation in the results 
between the different algorithms (see fig.3) and to 
obtain a final prediction of the secondary structure 
(denoted SS-PRED in figs l-3), it is necessary to 
interpret the individual predictions using an 
understanding of the main features of protein ar- 
chitecture. Of particular importance is that large 
proteins tend to form domains linked by sections 
of the polypeptide chain that are hydrophilic. 
These domains tend to belong to one of four struc- 
tural classes [24]: cu/cu, ,8/p, au/p and a+P. 
2.3. B-epitopes 
Here, algorithms to locate potential B- and T- 
epitopes [ 12,221 are refined by the identification of 
inter-strain sequence variability [ 141 and secondary 
structure prediction [ 14-171 and are applied to the 
env, gag and pol proteins. Interpretation of the 
secondary structure prediction also leads to the 
assignment of structural domains for the large pro- 
teins [24]. A preliminary account of this approach 
has been reported [6]. 
2. PROCEDURES 
The algorithm of Hopp and Woods [ 121 searches 
for a local maximum in a hydrophilicity profile 
smoothed over an average of 6 residues. The most 
hydrophilic peak was selected first and then others 
taken in order of hydrophilicity until on average 
there was one site per 30 residues of the polypep- 
tide chain. In figs 1-3, the numbers indicate the 
rank order of the peaks. The best candidates for 
vaccines, denoted by a + sign, were selected so 
that the 6 residues, and one residue before and 
after, were in a sequence-conserved region and on- 
ly one of the 6 residues overlapped with a predicted 
secondary structure. The other peaks are denoted 
by a - sign. 
The studies considered the lymphadenopathy- 
associated virus (LAV) [7] with the gag, pol and 
env sequence files identified by the Protein Infor- 
mation Resource Databank [25] codes FOVWLV, 
GNVWLV and VCLJLV. In addition, analyses of 
sequence variation (section 2.1) considered three 
other isolates - HTLV-III (FOVWH3, GNVWH3 
and VCLJH3); LV (FOVWVL, GNVWVL and 
VCLJVL) and ARV-2 (FOVWA2, GNVWA2 and 
VCLJA2). The following studies were performed 
and the results presented for LAV in figs l-3. 
2.4. T-epitopes 
The approach of DeLisi and Berzofsky [22] was 
applied. The amphipathicity of sections of 7 
residues was calculated and regions with a 
periodicity corresponding to that of an a-helix 
were identified. The letter T denotes the best vac- 
cine candidates where the section, and one residue 
before and after, is in a sequence-conserved 
region, otherwise a / is used. 
2.1. Sequence variation 3. RESULTS AND DISCUSSION 
A multiple alignment of the sequences of the 
four isolates was obtained [ 141. In the row denoted 
VARIABLE of the figures, the letter V indicates 
that there is sequence variability at this position 
whilst a G denotes that a gap was introduced into 
the alignment. 
We must emphasise that the description below 
refers to predicted secondary structures, domain 
links and epitopes, being only suggestions for ex- 
perimental verification. The env gene (fig. 1) begins 
with a hydrophobic signal peptide (residues 
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HTNXEKYQ ~~,*LN*C~~~-~~G~~~~*S~~ YmmNvii l+wVFldO 
VARIABLE VGWVVWVWVVV V 
wPpnnn&&m;;:~BLK:: 
V V 
SS-PRED HH mntQt 39955555 A 
El-EPITOeF: __-6__ __26__ __21__ __22___15__ 
T-EPITOPE ,,,/,, Trrm /1/,/, TlTrm 
130 140 150 160 170 180 190 200 210 220 230 240 
KLTFLCVSLKCTDLGNATNTNSSNTNSSSGEf4M4EK GEIKNCSFNISTSIRGKVQK~~LDIIPI~~~~VI~ACP~~P~PIHYC~AGFAILKCN~~G 
VARIABLE vv WV GG0XWWWG VVW VV GV VGGVV V V 
SS-PRED sssssssSss Hihmkkm sssssss sssssss ssssss 
B-EPITOPE __14__ ___5_- __10__ __2S__ 
T-EPITOPE Trrmr 
250 260 270 280 290 300 310 320 330 340 350 360 
TCE'CTRVSTVQCTtiGIRPVVSTQLLLNGSLAEEfS'VIRS ~AKTIIVQLNQSVEINCPRPNN~KSIRIQRGPGR~IGKIG~QIUICNIS~A~KQIASKLREQ~N 
zf%? v 
V V v v VGG VVVCGVVV vv V VV 
ssssss ssssssss sssss:ss ssssssssSssssss sssss -HHH 
R-EPITOPE __1,__ ++24+16++ __11__ 
'I'-EPITOPE ,/,,/,I 
370 360 390 400 410 420 430 440 450 460 470 480 
VARIABLE 
NKTI~~QSSCCDPEI~~~W~~~~~~~~~~I~~IKQFIl(mpLVCKAnY~PI~QI~CSSNITGLLLL~~NNNNGSEI~~~~ 
SS-PRED SSSSSS sssssss sssss A 
VGGVVV 
sssssss 
tJ-EPITOPE __23__ __2,__ __25__ + 
T-EPITOPE Trrmr ,/,I, 
490 500 510 520 530 540 550 560 570 580 590 600 
RDNMRSELYKYKVVKIEPLGVAPl'KAKRRWQREXRAVGIGAL FLGFU;MCSTIWRS~~Q~QLLSGIVQQQ~L~I~QQ~LQL~IKQLQ~I~~YLK~QL~I 
VARIABLE V V vv V V 
SS-PRD sssssssss ssssssss 
R-EPITOPE +12++ +++4++ +++*++ ___g__ 
T-EPITOPE Trl-Im 
610 620 630 640 650 660 670 680 690 700 710 720 
wsCSGKLICX'TAVPMJASt4SNKSLEQIMN nn*cMoREI~PrsLIHSLI~QNQQ~N~~LU~~~I~~IKIFI~I~L~~I~A~SIVNRVR~YSPL 
VARIABLE 
HHHd&~HHHV 
WVVV V 
SS-PRD SSSSSSS HHHHHHHHmmtiHHwHHHH 
B-EI'ITOPE --20-- +++2++ 
T-EPITOPE //,/1//1,/ Tmrr ,,,,,/,/,/, 
730 740 750 760 770 780 790 BOO 810 820 830 840 
VARIABLE 
SF~LPTPRCPDRPEGI~~~~S~RL~~~I~DLRS~L~~~LLLI~~~v~~K~Q~vQUKNSAVSLLNATAIAV~~RVI~~ 
vv V V V vv 
SS-PRED sssss ssssss HHHHHHHHHHHH HHHHHHHHHtMH HH"H""H 
Et-E?IMPE 
T-EPITOPE 
050 060 
ACRAIRHIPRRIRQGLERILL 
VARIABLE V V V V 
ss-PRED HHHHHHH HtiHHHHHHHH 
B-EPITOPE _-19.. __I*__ 
T-t?t'TTOPE ,////,I/ 
Fig.1. Analysis of the env gene. The LAV sequence [7] is given. SS-PRED gives the result of the final interpretation 
of the secondary structure prediction. H denotes an a-helix and S, a &sheet. 
10-28). After this until 130 there is a region 
predicted to be mainly cu-helices. Residues 130-165 
are devoid of structure and may well be a domain 
link. The next region is predicted to be rich in fl- 
sheets which is typical of the influenza virus 
glycoproteins, neuraminidase and haemagglutinin 
[26,27]. Residues 391-425 form another domain 
link to a region that ends at 516. This Lys/Arg-rich 
region is considered to be a proteolytic cleavage 
site [7] before the hydrophobic transmembrane a- 
helical section (517-532). There is another highly 
hydrophobic section (689-708) which would be 
suitable for another transmembrane a-helix. All 
the rest of the polypeptide chain (i.e. 533-688 and 
709-C-terminus) is not particularly hydrophobic 
and so we propose that only these two a-helical 
sections are buried in the membrane. Indeed, pep- 
tides from HTLV-III which correspond to residues 
501-529, 584-604 and 732-751 of LAV can raise 
antisera that recognise the virus [l-3] suggesting 
that these regions are not buried within the mem- 
brane. The first and third of these regions are 
predicted B-epitopes in our analysis. 
The analysis of the pal gene (fig.2) uses the pro- 
position of Johnson et al. [28] that the order of the 
proteins is: protease - reverse transcriptase - 
ribonuclease - endonuclease. The protease ends 
between residues 160 and 180 and mainly consists 
of &sheet structure. Residues 160-180 are a 
proline-rich region without LY- or &structure. The 
reverse transcriptase nds around residue 430 and 
is an a/,&structure. Sequence comparisons [28] 
have identified a consensus polymerase sequence 
around two conserved aspartate residues (340 and 
341). In addition, there is a conserved triplet LPQ 
(304-306) and a conserved doublet SP (311-312) 
233 
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,,*~~~S~*~~Q~~~~~~~-~~RPL~~~I~~~ LMGNudO 100 110 120 
VARIABLE GGGWV 
BSSS~SS 
mcSLFUlUtPKMIGGIGGPIKVRQYI)QILI 
v v 
ss-PRm SBSSSSSB SSBSSS 
B-BPITQPE __,9__ __3a__ 
SE __25__ ++2.++ 
T-EPITGPE Tllnm 
I30 140 150 160 170 180 190 200 210 220 230 240 
EICGHKAIcnnvcPrwRIIGRKLLTQI GcluJPPISPIEIvPVK~ PKVKplaraxIKALVEIfXFHXEGKISKIG~ 
VARIABLE 
AIKKKDBTlMKLMFRELRKRTQ 
SF-PREII ss sssssss BSSSSSSSSS sssss 5955539 S 
R-EPITOPE ++30++ __,3__ _-IO_- +++5++ .+11++ 
T-F.?ITOPE m 
250 260 270 280 290 300 310 320 330 340 350 360 
oFwnrQLGIP"PAGLKKKKsvnnaroAasvpDVGDAYpB"p ~AFTIPSIYIRTQ ~GBPAIPQBMIltI~KQKpDIVIYQYMC0LYVGSDLEIGQhRTKIFZT, 
VARIABLE V V 
SS-PRED sssssss ssssss 
a-FPITOPE ___9-- T 
ssssssss sssssss 
--1.6-- --14 
T-EPITGPETP 11,111, 
370 380 390 400 410 420 430 440 450 460 470 480 
RQHLLRffiLTPPDXKHQKEP~IXWIVQPI'JL ~IQKL~QIYPGIKVRQ~~IPL~EILK~SKDL 
VARIABLE V V V 
ldtwmuw 
V 
SS-PREO HHlMi36i I4lHlu 
R-EFITGPE -- +++6++ ++31++ ++15++ ++21++ --29- 
T-EPPITGPE 1,/,, Trrrrr 
490 500 510 520 530 540 550 560 570 580 590 600 
IAEIQKQG!FQ~QIYQEFPKWLKlGKY~AMDVK 
VARIABLE V 
QL1EhVPK~IVILPlQ~A~I~~~Q~I~~ 
V 
ss-PRm lwHmHn sssssss sssss 55595993 B-EPITGPE - __32__ 
T-EPITOPE ,,//,11/111 
610 620 630 640 650 660 670 680 690 700 710 720 
ASRFPKLGKAGYVTNRGR 
VARIABLE V V W 
Q~~Q~AI~QD~~I~QY~IIQAQ~vS~~II~LI~LAMIP~GI~~LVS~IR~~~I 
SS-PRFI) ssssssss sssss 59955359 m Ii- 
B-EPITGPE --22-- __I,__ ___I_- --2o-- __26__ 
T-EPITOPE 1/,,1,11 l-rim /I 
730 740 750 760 770 780 790 a00 a10 e20 830 a40 
DKAQDEHamSwwt~SM~~EIV~~CQ~G~~S~I~L UX%EGKWLVAVHVA.9G'IIuIIvIPAEXQEl'AYpLW RHPVKTfHlQNGSKFT%T 
VARIABLE _V 
SS-PRED 
a-EPITOPE ---7-- 
T-EPITGPE II/ 
V " 
5539995s p ssssssss S 
850 R60 a70 880 a90 900 910 920 930 940 950 960 
VARIABLE 
VKAACbUAGIKQEFGIPYNPQSQGVWS~l$ELXKIIGQVRCQ AMLI(TAVplU~I~~I~YS~I~IIA~I~ELQKQIIXIQ*FR~DS~p~Gp~L~G 
SS-PRED ssssssssss ssss m p S 
R-EZPITOPE __,2__ __23__ __33__ __2*-- ___)__ 
T-EPITOPE ,,,,, 1//,,/,,1 Trrrr 
970 980 990 1000 
ffiAWIQC4,SDIKWPRRKAKIIRDYGKQ MGDDCVASRQoa, 
"IPIARLE 
SS-PREI) 
;:+P;z, sssss::27--+++a++ ~ +++4++ 
Fig.2. Analysis of the pol gene, see legend to fig. 1. 
before this consensus ection. The secondary struc- 
ture prediction gives a ,L?c@ unit and all the con- 
served sequences would lie at the C-end of the two 
strands and at the N-terminus of the a-helix. This 
is reminiscent of a binding motif using the positive 
N-terminus of the a-helix to bind negatively 
charged phosphate groups such as in nucleotides 
[29]. Residues 370-405 form a proline-rich section 
devoid of LY- and p-structure. Johnson et al. [28] 
propose that residues 430-590 form a tether region 
between the reverse transcriptase and the 
ribonuclease. This section has a structure with cy- 
helices and p-strands arranged in a similar fashion 
to that of the reverse transcriptase. The 
ribonuclease (590-718) has an a +,&structure. The 
endonuclease (719-C-terminus) is predicted to 
adopt an a/&structure. 
The results for the gag polyproteins (fig.3) have 
been presented elsewhere [6]. In outline, p17 
(1-132) and p24 (133 to about 373) belong to the 
a/cu class of proteins. The last 40 residues of p17 
and residues 220-260 of p24 are probably exposed 
loops that would be ideal candidates for 
stimulating a B-cell antigenic response. The C- 
terminal section, ~15, is predicted not to have 
regular secondary structure. 
Individually secondary structure algorithms 
have accuracies of between 50% and 65% for 
prediction of a- and &structures. However, 
regions where there is agreement from several 
methods have been shown to be predicted more ac- 
curately [30]. To provide an indication of the con- 
sistency of the individual predictions, the results of 
the individual algorithms are given in fig.3. 
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VARIABLE 
,,S”L~,DR~:LR,KK~~“I~S~~~PA~~L~S~R~~~L*PSL~S~*B‘~A~Y~~**~~~I~~~SKKK*QQ~ 
” V G 
ZVELEBIL HHHHH HHHunHHH HHHHH HHHHHHHHHHHHH 3595 HHHHHH SSSSSSS1 
CF HlBENo BBBB-BBBBBBBB BBBB BBBBBBBBHHHHHH HBB_ 
Cf SHEEX SSSSSS sssssss sSssssssssssssssssss 
LIc( SSSSSS HHHm 
ROSE BEND BBBBB BBBBB BBBBB BBBBB BBBBBB BBB BBB BBB 
SS-PRED HHHHlMiHWd 
B-EPITOPE --,6-++,,++-9-- -__6__ --17---5--lO---1++3+++2++ 
T-EPITOPE ,//,,I 
130 140 150 160 170 180 190 200 210 220 230 240 
DXHSSQVSQNVPIVQNIQGQM”HQAISPRTLNAH”K””EEKAFSP!Z”I~SALS~ATPQDL HMLKNGGHQAAHQWLKETI NEEAUMDRVHWHAGPIAFGQHREPRGSDIAGlT 
VARIABLE G V V 
ZVELEBIL sssssss SSSSSSS ssssss p _____________... SSSS 
CF H/BmD BBBB BBBB mBBBHBBBB_ BBBB BBBB tMiI+lM m BBBB BBBB BBBB 
CF SHFzEr ssssssssssssss SSSSSSSS SSSS sssss 
LIM HHmHHIDI ssssss ac ssssss 
ROSE BEND BBB BBBBB BBBBS BBBBB 888 I SBBBB BBBBB 
SS-PRD HHm m 
S-EPITOPE __13__ ++12++ 
T-EPITOPE Tl-mr 1.rrrrrr1 
VARIABLE 
Z”ELEB1 L 
CF HlSE”D 
cFSHE?Z 
LIM 
ROSE BFND 
SS-PRED 
R-EPITOPE 
T-FPITOPE 
250 260 270 280 290 300 310 320 330 340 350 360 
STLQEQIG~NNPPIWGEIYKRWIILGLNKIVRPIYSPTSILDIR~PKEPFRDWDRFYK~R~~Q~ ~LVQN~PaXTIW~AC~ffi~A 
” 
SSSSS ssssssssssss SSBSSS SSSSS HHHH- ssssss - hH 
HHW BBBB twW+HHH HHHH#MI BBBB”HH”“HBBBB BBBB BBBB BBBI BBBBHH 
SSSSSS SSSSSSSS ssssssss 955395555585 ssssss SSSSSSSS 
HHlMmHHHHHHHHH ssss -HHnmwmm HHH 
BBBB BBBB BBBBB BBBBBB BBBBB BBBBB BBBBB BBBB 
HHJMHHHHHH H 
+15+11++ 
TITnTrrTlTnn-r ,I/ ,/,//, Tmrmmrrm 
370 380 390 400 410 420 430 440 450 460 470 480 
RVLIIEILnSQ~SATInQRG~NQRKIVKCFNCGKECHIARHCRAPRKKGCWKCGKECHPI(I(DSG VGmPSQKQEPID 
“AR I ABLE vv ” V” ” v 
ZVELESIL HHHHHHHHHl-M SSSSS sss 
CF H/BEND HHIWHHHHHH BBBS BBBB BBBB BBBB BBBB BBBB HHHHHH HIDDDDDDl BBBB BBBB BBBB BBBB BBBB BBBB HHHHH 
CF SHEFP SSSSS SSSS sssss SSSSS 
LIt4 HHHH”HHHHH SSSSS mm ssssss 
ROSE BEND B BBBBB BBBB BBBBB BBBB BBEIBB BBBBB BBB BBBBB BBBBBBB 
SS FRED HHHHHHHHHH 
R-EPITOPE +++4++ +++7++ 
___S 
T-EPITOPE m //,/,/1/1 
490 500 
KELYPLTSLRSLFGNDPSSQ 
VARIABLE VwwwmGGGGGG 
ZVELEBIL 
CF HlSEND HHH BBBB 
rF SHEET SSSSS SSSSS 
LIM SSSSS 
ROSE BEND B BBB 
SS-PREC 
B-EPITOPE -- 
T-EPIMFE 
Fig.3. Analysis of the gag gene. The results of the individual secondary structure predictions are given with B denoting 
bend (i.e. turn) regions. CF indicates the approach of Chou and Fasman [IS] and all potential cu-helices and &sheets 
are given for later selection using the results from the other predictions. 
The algorithm to locate B-epitopes tends to 
overpredict with sections of chain located that, as 
yet, are not known to be antigenic [12]. According- 
ly, our prediction of B-epitopes used an additional 
constraint that the chain section is not in a secon- 
dary structure. This approach is however a 
simplification designed to suggest he most likely 
B-epitopes but after these candidates have been 
tried, attention should focus on predicted B- 
epitopes that overlap with a predicted secondary 
structure. Indeed, in foot and mouth disease virus, 
a major B-epitope lies within residues 141-160 of 
the capsid polypeptide VP1 but this region is 
predicted by the approach of Chou and Fasman 
[15] to be a-helical [31]. 
The difficulty of predicting B-epitopes can be 
seen from a comparison of our results and those of 
Robson and co-workers [5] on the WV protein. We 
locate 5 good candidates for B-epitopes (denoted 
+) whilst Robson et al. [5] suggest 7 sections. 
Residues 480-485, 503-515 and 659-665 in our 
predictions correspond to sites 6, 7 and 1 of Rob- 
son et al. [5]. Sites 2 and 4 of Robson et al. [5] 
(residues 75-84 and 367-375) are predicted poten- 
tial B-epitopes of rank 21 and 23 but we do not 
consider them as good candidates due to overlaps 
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with a predicted secondary structure and a region 
of sequence variability, respectively. Sites 3 and 5 
of Robson et al. [5] are not predicted as B-epitopes 
by the algorithm of Hopp and Woods [12]. Our 
site around residues 303-311 is probably not 
predicted by Robson et al. IS] as they exclude 
potential glycosylation sites and residues 305-307 
have the sequence NNT. The most hydrophilic 
peak of Hopp and Woods’ algorithm [12] is 
745-749 and forms one of our sites but is not 
predicted by Robson et al. [5], possibly due to se- 
quence variation nearby. 
T-epitope predictions are still in the early stage 
of development and a different approach is being 
developed (Rothbard, J. and Taylor, W.R. per- 
sonal communication). This gives predictions with 
substantial overlap with the algorithm of DeLisi 
and Berzofsky [22]. Thus, both the B- and T- 
epitope predictions must be considered as sugges- 
tions that should be refined as improved 
algorithms are developed. 
4. CONCLUSION 
Studies on other proteins, such as influenza 
haemagglutinin and VP1 of polio [32], have used 
B-epitope predictions to design synthetic peptide 
vaccines that yield some protection in animals. We 
have located B- and T-epitopes in sequence- 
conserved regions in all three HIV-l gene 
products. These epitopes in env, gag and possibly 
pol should be considered as candidates for vac- 
cines. This paper proposes that the best vaccine 
candidates are those sections with both B- and T- 
epitopes in sequence-conserved regions. Because of 
the variability of the env sequences, no 15-30 
residue section meets this condition and this 
suggests that larger sections of the molecule should 
be used. However, in gag, which has a more 
conserved sequence than env, a short peptide 
containing residues 288-304 (GPKEPFRDY- 
VDRFYKTL) meets this condition and may be 
effective as a synthetic vaccine. Although there is 
no evidence yet that the immune response to any 
pol proteins is important clinically, this analysis 
shows that, as these proteins have highly conserved 
sequences, there are several short regions which 
meet the condition and might well prove successful 
as peptide vaccines. These considerations are 
236 
affecting our decisions as to which peptides to 
synthesise for in vitro testing as vaccines. 
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